Voluntis
2022 Look Ahead
Participants in HealthTech Build's recent panel discuss the barriers to adoption for digital therapeutics.
Also: 1Drop's portable diagnostics tackle the final frontier; AT&T, partners look to streamline patient check-in.
Oleena's algorithms serve patients personalized guidance on how best to mitigate symptoms, while also monitoring and generating insights for their care team.
Clinical research software company Elligo Health Research has entered a partnership with HealthiVibe, a company that collects patient insights in order to improve clinical trials.
Digital therapeutics may be up and coming, but they also have a long way to go before their mainstream treatment options, according to experts who spoke at the digital therapeutics deep dive at HIMSS18.
Correction: A previous version of this story mistated the projected timeline for the combined product.
French companion app company Voluntis has partnered with AstraZeneca to develop an app for women undergoing treatment for ovarian cancer.
Voluntis's Diabeo app, not available in the United States
French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer.
By the end of the second quarter this year, digital health funding had already surpassed the total funding for 2014, according to a June 2014 report from Rock Health.